Northern Trust Corp increased its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 59.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 356,031 shares of the company's stock after acquiring an additional 132,601 shares during the period. Northern Trust Corp owned about 0.07% of Nutrien worth $15,932,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in the business. Covea Finance lifted its position in shares of Nutrien by 21.9% during the fourth quarter. Covea Finance now owns 55,600 shares of the company's stock worth $2,485,000 after purchasing an additional 10,000 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Nutrien by 8.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,886,376 shares of the company's stock worth $84,367,000 after buying an additional 144,025 shares during the last quarter. Van ECK Associates Corp raised its stake in shares of Nutrien by 5.7% during the fourth quarter. Van ECK Associates Corp now owns 1,480,870 shares of the company's stock worth $66,264,000 after buying an additional 80,382 shares during the last quarter. Secured Retirement Advisors LLC bought a new stake in shares of Nutrien during the fourth quarter worth approximately $654,000. Finally, Abel Hall LLC bought a new stake in Nutrien in the fourth quarter valued at approximately $276,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Price Performance
Shares of NYSE:NTR traded up $0.78 during trading on Tuesday, reaching $58.76. The stock had a trading volume of 142,805 shares, compared to its average volume of 2,130,201. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The business has a fifty day moving average price of $52.77 and a 200-day moving average price of $50.37. The stock has a market cap of $28.69 billion, a PE ratio of 42.80, a PEG ratio of 1.19 and a beta of 0.79. Nutrien Ltd. has a 1-year low of $43.70 and a 1-year high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $4.67 billion for the quarter, compared to analysts' expectations of $5.16 billion. During the same quarter last year, the company earned $0.46 EPS. Nutrien's revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.
Nutrien Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.71%. The ex-dividend date is Monday, June 30th. Nutrien's dividend payout ratio (DPR) is 203.74%.
Wall Street Analysts Forecast Growth
NTR has been the subject of several recent analyst reports. Berenberg Bank upped their target price on shares of Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research note on Tuesday, April 15th. Barclays upped their price target on shares of Nutrien from $59.00 to $61.00 and gave the company an "equal weight" rating in a report on Wednesday, May 14th. Bank of America upped their price target on shares of Nutrien from $60.00 to $63.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. The Goldman Sachs Group upped their price target on shares of Nutrien from $53.00 to $59.00 and gave the company a "sell" rating in a report on Friday, May 9th. Finally, BNP Paribas raised shares of Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $61.44.
Read Our Latest Stock Report on NTR
About Nutrien
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
